Novel inflammation-based model for postoperative early recurrence prediction of hepatitis B virus-related hepatocellular carcinoma ≤ 5 cm

Figure 4 Evaluation of the predictive efficacy of the inflammation-related score-based nomogram model for early recurrence of hepatitis B virus-related hepatocellular carcinoma ≤ 5 cm in a validation cohort. A: Calibration curves based on the nomogram for early recurrence prediction in the validation cohort; B: Receiver operating characteristic curves of the nomogram and other parameters and staging systems for discrimination evaluation of the early recurrence-free survival (RFS) in the validation cohort; C and D: Decision analysis curves for beneficial evaluation of the nomogram and other parameters and staging systems for early RFS in the validation cohort. RFS: Recurrence-free survival; IRS: Inflammation-related score; AUC: Areas under the curve; MVI: Microvascular invasion; BCLC: Barcelona Clinic Liver Cancer; TNM: Tumor-node-metastasis; CNLC: China Liver Cancer.